Indian billionaire Dilip Shanghvi is the founder and managing director of Sun Pharmaceutical Industries. He has an estimated net worth of $18 billion as of 2015, according to Forbes. This decline to about $11 billion as of October 2018.
Dilip was born on 1 October 1955 in Amreli, Gujrat. He studied at the J. J. Ajmera High School and Bhawanipur Education Society College. He gained his bachelor of commerce degree from the University of Calcutta.
Shanghvi began his career by helping his father in his wholesale generic drugs business. It was during those days that he thought of manufacturing his own drugs. He founded Sun Pharmaceutical Industries in 1982 at Vapi, with a capital of around $155. Today the company is regarded as the most valuable drug company in India. It is also the largest drug maker in the country.
In order to expand Sun’s reach in the US, Shanghvi acquired loss-making American company Caraco Pharma in 1997 and turned it around. The US now accounts for around 60 percent of Sun’s revenue. He acquired Israel’s Taro Pharma in 2007. Sun completed the $3.2 billion acquisition of Ranbaxy Laboratories Ltd in 2015, after almost a year of navigating the regulatory gauntlet.
Shanghvi is married and has two children. The family lives in Mumbai.